Dectahan, Zaira Joy A.
HRN: 22-50-86 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2023
CEFTAZIDIME 1GM (VIAL)
01/26/2023
02/02/2023
IV
55mg
Q12
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes